Prelude Therapeutics Inc
Recent Filings
All 358 filings →Insider Transactions
View all →| Insider | Title | Type | Shares | Owns After | Date |
|---|---|---|---|---|---|
| Combs Andrew | Chief Chemistry Officer | Purchase | 100,000 @ $0.69 | 480,123 | Mar 25, 2025 |
| Vaddi Krishna | CEO | Purchase | 675,000 @ $0.69 | 1,999,296 | Mar 25, 2025 |
| Vaddi Krishna | CEO | Purchase | 15,000 @ $0.73 | 1,324,296 | Mar 20, 2025 |
| Vaddi Krishna | CEO | Purchase | 29,999 @ $0.75 | 1,294,774 | Mar 17, 2025 |
| Vaddi Krishna | CEO | Purchase | 50,000 @ $0.72 | 1,264,775 | Mar 12, 2025 |
| Vaddi Krishna | CEO | Purchase | 5,000 @ $1.21 | 142,553 | Dec 31, 2024 |
| Vaddi Krishna | CEO | Purchase | 10,000 @ $1.20 | 137,553 | Dec 30, 2024 |
| Combs Andrew | Chief Chemistry Officer | Purchase | 60,000 @ $1.37 | 377,623 | Dec 20, 2024 |
| Lim Bryant David | CLO, Interim CFO, Corp Sec. | Purchase | 25,000 @ $0.91 | 27,400 | Dec 19, 2024 |
| Vaddi Krishna | CEO | Purchase | 6,888 @ $0.89 | 127,553 | Dec 18, 2024 |